Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Eur J Radiol ; 148: 110159, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35065483

ABSTRACT

PURPOSE: The aim of this study was to compare image quality of computed tomography (CT) images with and without orthopedic metal artifact reduction (O-MAR) in the follow-up of patients after sacroiliac (SI) joint fusion. METHODS: Thirty-six consecutive patients (31 females and 5 males) undergoing CT within 24 h after SI joint fusion were included. CT images were reconstructed with and without O-MAR and scored by two radiologists with over 20 years of experience using a six-point ordinal scale. Images were scored on overall image quality and five criteria that are important to the clinician for the follow-up of patients after SI joint fusion. In addition, images were scored on how well four bony structures could be delineated. Wilcoxon signed-ranks tests with Holm-Bonferroni correction were used to test for differences between the radiologists' scores on CT images with and without O-MAR. RESULTS: Both radiologists scored overall image quality significantly higher (p < 0.05) on the images without O-MAR than on the images with O-MAR. In addition, two of the follow-up criteria, delineation of the sacrum and delineation of the implanted ilium were scored significantly higher (p < 0.05) on the images without O-MAR. Neither radiologist scored the images with O-MAR significantly higher than the images without O-MAR for any of the criteria. CONCLUSION: CT imaging without O-MAR provided higher image quality and better assessment of SI joint fusion follow-up criteria compared to CT imaging with O-MAR in the follow-up of patients after SI joint fusion.


Subject(s)
Artifacts , Sacroiliac Joint , Algorithms , Female , Humans , Male , Metals , Sacroiliac Joint/diagnostic imaging , Tomography, X-Ray Computed/methods
2.
Injury ; 53(2): 506-513, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34656318

ABSTRACT

BACKGROUND: Recently, Rommens and Hoffman introduced a CT-based classification system for fragility fractures of the pelvis (FFP). Although fracture characteristics have been described, the relationship with clinical outcome is lacking. The purpose of this study was to get insight into the type of treatment and subsequent clinical outcome after all types of FFP. METHODS: A cross-sectional cohort study was performed including all elderly patients (≥ 65 years) with a CT-diagnosed FFP, between 2007-2019 in two level 1 trauma centers. Data regarding treatment, mortality and clinical outcome was gathered from the electronic patient files. Patients were asked to complete patient-reported outcome measures (PROMs) regarding physical functioning (SMFA) and quality of life (EQ-5D). Additionally, a standardized multidisciplinary treatment algorithm was constructed. RESULTS: A total of 187 patients were diagnosed with an FFP of whom 117 patients were available for follow-up analysis and 58 patients responded. FFP type I was most common (60%), followed by type II (27%), type III (8%) and type IV (5%). Almost all injuries were treated non-operatively (98%). Mobility at six weeks ranged from 50% (type III) to 80% type II). Mortality at 1 year was respectively 16% (type I and II), 47% (type III) and 13% (type IV). Physical functioning (SMFA function index) ranged from 62 (type III and IV) to 69 (type II) and was significantly decreased (P=<0.001) compared to the age-matched general population. Quality of life was also significantly decreased, ranging from 0.26 (type III) to 0.69 (type IV). CONCLUSIONS: FFP type I and II are most common. Treatment is mainly non-operative, resulting in good mobility after six weeks, especially for patients with FFP type I and II. Mortality rates at one year were substantial in all patients. Physical functioning and quality of life was about 20-30% decreased compared to the general population.


Subject(s)
Fractures, Bone , Osteoporotic Fractures , Pelvic Bones , Aged , Cross-Sectional Studies , Humans , Osteoporotic Fractures/diagnostic imaging , Osteoporotic Fractures/therapy , Pelvic Bones/diagnostic imaging , Pelvis/diagnostic imaging , Quality of Life , Retrospective Studies , Tomography, X-Ray Computed
3.
JPEN J Parenter Enteral Nutr ; 29(4): 298-304, 2005.
Article in English | MEDLINE | ID: mdl-15961687

ABSTRACT

Recent studies have shown that fasting during the preoperative period for elective surgery induces a metabolic state that seems unfavorable for patients. Results from animal studies indicate that rapid depletion of liver glycogen before surgery leads to mobilization of muscle glycogen after surgery, in turn leading to reduced muscle strength. Depletion of liver glycogen also influences the function of the mononuclear phagocytic system (MPS), which is located predominantly in the liver. The MPS is essential in restricting endotoxin, which may translocate from the gut. In addition, surgery per se puts a substantial physical strain on the patient, and fasting may adversely affect the metabolic response to surgery. This paper presents experimental and clinical data that, when combined together, prove that fasting before surgery has adverse consequences for the patient.


Subject(s)
Fasting/adverse effects , Fasting/physiology , Glycogen/metabolism , Preoperative Care/methods , Animals , Disease Models, Animal , Fasting/metabolism , Humans , Liver Glycogen/metabolism , Muscle, Skeletal/metabolism , Phagocytosis
4.
Eur J Clin Nutr ; 58(4): 587-93, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15042126

ABSTRACT

OBJECTIVE: In physiological conditions, the liver plays an important role in the regulation of plasma arginine concentrations by taking up large amounts of arginine from the hepatic circulation. When hepatic failure is present, arginine metabolism may be disturbed. Therefore, we hypothesized high arginine plasma concentrations in critically ill patients suffering from hepatic failure. DESIGN: We prospectively collected blood samples from a cross-section of intensive care unit patients. SETTING: Surgical intensive care unit of a Dutch university medical center. SUBJECTS: A total of 52 critically ill patients with clinical evidence of dysfunction of more than two organs were recruited. MEASUREMENTS: Plasma arginine concentrations were determined by HPLC. We identified correlations of arginine concentrations with organ failure scores and laboratory variables by univariate and multiple regression analyses. RESULTS: High plasma arginine concentrations were found in critically ill patients developing organ failure. Patients who were in the highest quartile of plasma arginine concentrations had significantly lower fibrinogen concentrations, higher lactic acid concentrations, and longer prothrombin time. Stepwise multiple regression analysis showed that concentrations of arginine were independently associated with the presence of hepatic failure (P=0.03) and renal failure (P=0.048). In addition, lactic acid proved to be an independent determinant of plasma arginine concentration (P=0.014). CONCLUSIONS: Critically ill patients who suffer from hepatic failure have elevated plasma arginine concentrations. Additional arginine in the treatment of these patients can be harmful, and therefore should not be used as a standard nutritional regimen until further evaluation.


Subject(s)
Arginine/blood , Liver Failure/blood , Renal Insufficiency/blood , Adolescent , Adult , Aged , Aged, 80 and over , Critical Illness , Cross-Sectional Studies , Female , Humans , Intensive Care Units , Lactic Acid/blood , Male , Middle Aged , Netherlands
5.
Clin Nutr ; 22(1): 17-22, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12553945

ABSTRACT

BACKGROUND AND AIMS: Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthase enzymes, whereas symmetrical dimethylarginine (SDMA) competes with arginine transport. Although both dimethylarginines may be important regulators of the arginine-NO pathway, their metabolism is largely unknown. Both dimethylarginines are removed from the body by urinary excretion. However, ADMA is also subject to enzymatic degradation by the enzyme dimethylarginine dimethylaminohydrolase (DDAH), which is highly expressed in the liver. To elucidate the role of the liver in the metabolism of ADMA, we aimed to investigate dimethylarginine handling of the liver in detail. METHODS: Ten male Wistar rats were used for this study. Blood flow was measured using radiolabeled microspheres according to the reference sample method. Concentrations of dimethylarginines were measured by HPLC. The combination of arteriovenous concentration difference and organ blood flow allowed calculation of net organ fluxes and fractional extraction rates. RESULTS: Both the liver (0.89+/-0.11) and the kidney (0.68+/-0.06) showed a high net uptake (nmol/100 g body weight (BW)/min) of ADMA, whereas a significant net uptake of SDMA was only observed in the kidney (0.34+/-0.04). For the liver, fractional extraction rates were 29.5% +/-3.0 for ADMA and 0.0%+/-3.7 for SDMA. Fractional extraction rates of ADMA and SDMA for the kidney were 36.0%+/-2.7 and 31.6%+/-3.8, respectively. CONCLUSIONS: The liver plays an important role in the metabolism of ADMA by taking up large amounts of ADMA from the systemic circulation.


Subject(s)
Arginine/analogs & derivatives , Arginine/metabolism , Enzyme Inhibitors/metabolism , Liver/metabolism , Animals , Chromatography, High Pressure Liquid , Kidney/blood supply , Liver/blood supply , Liver Circulation/physiology , Male , Rats , Rats, Wistar , Regional Blood Flow/physiology , Renal Circulation/physiology
6.
Clin Nutr ; 22(1): 23-30, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12553946

ABSTRACT

BACKGROUND AND AIMS: Accumulation of asymmetrical dimethylarginine (ADMA) has been linked to endothelial dysfunction, and is an important risk factor for cardiovascular disease. Its elimination from the body is dependent on urinary excretion and degradation by the enzyme dimethylarginine dimethylaminohydrolase. This enzyme is highly expressed in the liver, and in rat studies a high net hepatic uptake of asymmetrical dimethylarginine was found. In critically ill patients, we investigated the relation between indicators of renal and hepatic dysfunction and plasma ADMA concentration, and tested the association between ADMA concentration and outcome. METHODS: We prospectively collected blood samples from a cross-section of critically ill patients (n=52) with clinical evidence of dysfunction of more than two organs. We identified correlates of plasma ADMA concentration with laboratory values, organ failures score and outcome by univariate and multiple regression analyses. RESULTS: In critically ill patients, plasma ADMA concentration was independently related to the presence of hepatic failure (b=0.334, 95% CI: 0.207-0.461; P<0.001), and to lactic acid (b=0.395, 95% CI: 0.230-0.560; P<0.001) and bilirubin (b=0.121, 95% CI: 0.031-0.212; P=0.009) concentration as markers of hepatic function. Twenty-one (40%) patients deceased during their ICU stay. In a logistic regression model, plasma ADMA ranked as the first and strongest predictor for outcome, with a 17-fold (95% CI: 3-100) increased risk for ICU death in patients who were in the highest quartile for ADMA. CONCLUSIONS: In critically ill patients, plasma ADMA concentration is a strong and independent risk factor for ICU mortality, and hepatic dysfunction is the most prominent determinant of ADMA concentration in this population.


Subject(s)
Arginine/analogs & derivatives , Arginine/blood , Critical Illness/mortality , Enzyme Inhibitors/blood , Intensive Care Units , Liver Failure/blood , Multiple Organ Failure/blood , Multiple Organ Failure/mortality , Renal Insufficiency/blood , Adult , Aged , Analysis of Variance , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pilot Projects , Risk Factors
7.
Clin Nutr ; 22(1): 99-104, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12553957

ABSTRACT

Development of multiple organ failure is the most complex problem in critically ill patients, and is associated with a high mortality. Asymmetrical dimethylarginine (ADMA) is an endogenously produced inhibitor of nitric oxide synthase, of which the clinical importance is currently being revealed. In Nijveldt et al. (The liver is an important organ in the metabolism of asymmetrical dimethylargenine (ADMA) Clin Nutr 2003; 22: 17-22) we showed that plasma ADMA concentration is elevated in critically ill patients and significantly related to hepatic function. Moreover, plasma ADMA concentration emerged as a strong and independent risk factor for ICU mortality in these patients. Here, we hypothesize that accumulation of ADMA is a causative factor in the development of multiple organ failure by interfering with important physiological functions of nitric oxide production.


Subject(s)
Arginine/analogs & derivatives , Arginine/adverse effects , Arginine/metabolism , Enzyme Inhibitors/adverse effects , Enzyme Inhibitors/metabolism , Multiple Organ Failure/etiology , Multiple Organ Failure/metabolism , Critical Illness , Humans , Liver/physiopathology , Nitric Oxide/biosynthesis
8.
J Nutr ; 131(9 Suppl): 2569S-77S; discussion 2590S, 2001 09.
Article in English | MEDLINE | ID: mdl-11533315

ABSTRACT

Glutamine should be reclassified as a conditionally essential amino acid in the catabolic state because the body's glutamine expenditures exceed synthesis and low glutamine levels in plasma are associated with poor clinical outcome. After severe stress, several amino acids are mobilized from muscle tissue to supply energy and substrate to the host. Glutamine is one of the most important amino acids that provide this function. Glutamine acts as the preferred respiratory fuel for lymphocytes, hepatocytes and intestinal mucosal cells and is metabolized in the gut to citrulline, ammonium and other amino acids. Low concentrations of glutamine in plasma reflect reduced stores in muscle and this reduced availability of glutamine in the catabolic state seems to correlate with increased morbidity and mortality. Adding glutamine to the nutrition of clinical patients, enterally or parenterally, may reduce morbidity. Several excellent clinical trials have been performed to prove efficacy and feasibility of the use of glutamine supplementation in parenteral and enteral nutrition. The increased intake of glutamine has resulted in lower septic morbidity in certain critically ill patient populations. This review will focus on the efficacy and the importance of glutamine supplementation in diverse catabolic states.


Subject(s)
Dietary Supplements , Glutamine/therapeutic use , Stress, Physiological/therapy , Acquired Immunodeficiency Syndrome/therapy , Controlled Clinical Trials as Topic , Critical Care , Elective Surgical Procedures , Enteral Nutrition , Glutamine/blood , Glutamine/metabolism , Humans , Nutritional Status , Parenteral Nutrition, Total , Stress, Physiological/blood , Stress, Physiological/metabolism , Wounds and Injuries/therapy
9.
Am J Clin Nutr ; 74(4): 418-25, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11566638

ABSTRACT

The aim of this review, a summary of the putative biological actions of flavonoids, was to obtain a further understanding of the reported beneficial health effects of these substances. Flavonoids occur naturally in fruit, vegetables, and beverages such as tea and wine. Research in the field of flavonoids has increased since the discovery of the French paradox,ie, the low cardiovascular mortality rate observed in Mediterranean populations in association with red wine consumption and a high saturated fat intake. Several other potential beneficial properties of flavonoids have since been ascertained. We review the different groups of known flavonoids, the probable mechanisms by which they act, and the potential clinical applications of these fascinating natural substances.


Subject(s)
Antioxidants/therapeutic use , Flavonoids , Food , Flavonoids/adverse effects , Flavonoids/pharmacokinetics , Flavonoids/therapeutic use , Humans
10.
Eur J Vasc Endovasc Surg ; 22(3): 232-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11506516

ABSTRACT

BACKGROUND: Ischaemic renal dysfunction is present in many clinical settings, including cardiovascular surgery. Renal hypoperfusion seems to be the most important pathophysiologic mechanism. Arginine plasma levels are rate limiting for NO synthesis, and low arginine plasma levels are seen after major vascular surgery. OBJECTIVE: to establish the effects of low arginine plasma levels on renal blood flow after renal ischaemia/reperfusion. DESIGN: Wistar rats were used in this unilateral renal ischaemia/reperfusion model. After 70 min of ischaemia, the kidney was reperfused for 150 min. Arginase infusion was used to lower arginine plasma levels. Blood flow measurement was performed at the end of the experiment using radiolabelled microspheres. Additional experiments were performed for histopathology. RESULTS: Arginase efficiently decreased arginine plasma levels to about 50% of normal. There was a lower blood flow in the ischaemic kidney than the contralateral (non-ischaemic) kidney. Lowering arginine plasma levels did not reduce renal blood flow in the ischaemic kidney. Renal histopathology was not influenced by lowered arginine plasma levels. CONCLUSIONS: Lowering arginine plasma levels did not affect blood flow or histology following renal ischaemia and reperfusion.


Subject(s)
Arginine/blood , Ischemia/blood , Ischemia/physiopathology , Kidney Diseases/blood , Kidney Diseases/physiopathology , Renal Circulation/drug effects , Animals , Arginase/pharmacology , Arginine/drug effects , Disease Models, Animal , Hemodynamics/drug effects , Ischemia/therapy , Kidney Diseases/pathology , Kidney Diseases/therapy , Male , Probability , Random Allocation , Rats , Rats, Wistar , Reperfusion/methods , Sensitivity and Specificity , Statistics, Nonparametric
11.
Shock ; 16(2): 113-5, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11508862

ABSTRACT

Arginine stimulates lymphocyte function and is degraded by arginase, an enzyme that is abundantly present in red blood cells. Arginase impairs lymphocyte function and responses in vitro. Leakage of arginase from stored red blood cells may be involved in the lymphocyte dysfunction associated in allogenic blood transfusion. In the present study, arginase activity was determined in bags of red cells stored for transfusion. Buffy coat depleted red blood cells were obtained routinely from four healthy donors and stored in bags for a maximum period of five weeks at 4 degrees C. The bags were sampled for determination of arginase, lactate dehydrogenase, and potassium. In addition, a random sample of 36 bags of red blood cells about to be transfused to patients were studied. Levels of arginase, lactate dehydrogenase, and potassium showed a time dependent increase in the bags of the four donors. This time dependent increase in arginase activity could be confirmed in the additional bags sampled (P < 0.0001, r = 0.78). The results for the first time show that arginase is released from red blood cells during storage for transfusion. Arginase infusion may play an important role in the immune suppression observed after blood transfusion.


Subject(s)
Arginase/blood , Blood Transfusion , Erythrocytes/enzymology , Blood Donors , Blood Preservation , Humans , Immunosuppression Therapy/methods , L-Lactate Dehydrogenase/blood , Potassium/blood , Time Factors
12.
Ann Acad Med Singap ; 30(3): 226-33, 2001 May.
Article in English | MEDLINE | ID: mdl-11455733

ABSTRACT

INTRODUCTION: Major hepatic resections are still associated with considerable morbidity. Gut-derived bacteria and bacterial endotoxin are considered to play a central role in the pathophysiology of complications. Experimental studies suggest that bactericidal/permeability-increasing protein (BPI), which has both antibacterial and endotoxin-neutralising properties, can reduce postoperative complications. MATERIAL AND METHODS: A phase II, double-blind, placebo-controlled, multicentre, dose escalation trial was conducted in patients undergoing major liver resection, and clinical outcome, infectious complications, plasma amino acid patterns, coagulation and fibrinolytic cascade systems and neutrophil functions were compared between the two treatment groups and an extra group of patients undergoing major abdominal non-hepatic surgery. RESULTS: Drug administration in this patient group was safe, and resulted in a significant reduction of infectious complications. Furthermore, beneficial effects were found in the postoperative amino acid ratio and fibrinolytic cascades, and rBPI21 preserved leukocyte functions. CONCLUSION: Administration of rBPI21 in patients undergoing major liver resection is well tolerated and results in improvement of both clinical and biochemical parameters.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Blood Proteins/therapeutic use , Liver/surgery , Membrane Proteins , Perioperative Care , Surgical Wound Infection/drug therapy , Surgical Wound Infection/prevention & control , Adult , Amino Acids/blood , Amino Acids/drug effects , Anti-Bacterial Agents/administration & dosage , Antimicrobial Cationic Peptides , Blood Coagulation/drug effects , Blood Proteins/administration & dosage , Dose-Response Relationship, Drug , Double-Blind Method , Hepatectomy/adverse effects , Humans , Liver/metabolism , Neutrophils/drug effects , Surgical Wound Infection/blood , Treatment Outcome
13.
Shock ; 15(4): 261-71, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11303724

ABSTRACT

This prospective study investigated the role of reduced hepatic synthesis of regulating proteins in coagulopathy after partial hepatectomy (PH) compared with major abdominal surgery (MAS) without involvement of the liver. Furthermore, we studied the effect of rBPI21, an endotoxin-neutralizing agent, on coagulopathy after PH was studied. Compared with MAS, PH resulted in significantly elevated levels of thrombin-antithrombin-III and plasmin-alpha2-antiplasmin complexes. Levels of antithrombin-3, alpha2-antiplasmin, fibrinogen, plasminogen, alpha2-macroglobulin (alpha2-M), and C1-inhibitor remained lower following PH. Treatment with rBPI21 led to significantly lower levels of tissue-type plasminogen activator (t-PA). Post-operative disseminated intravascular coagulation (DIC) was associated with significantly higher bilirubin and t-PA plasma levels and significantly lower levels of alpha2-M. This study indicates that PH induced hepatic failure results in decreased synthesis of hepatic regulating plasma proteins and subsequent activation of coagulation and fibrinolysis. Prevention of t-PA release by rBPI21 may have important clinical implications. Decreased availability of alpha2-M may be a factor in post-operative DIC.


Subject(s)
Blood Coagulation Factors/biosynthesis , Disseminated Intravascular Coagulation/etiology , Endotoxemia/etiology , Hepatectomy/adverse effects , Liver/metabolism , Membrane Proteins/therapeutic use , Abdomen/surgery , Adult , Aged , Antithrombin III/analysis , Bacterial Translocation , Bilirubin/blood , Biomarkers/blood , Comorbidity , Complement C1 Inactivator Proteins/analysis , Disseminated Intravascular Coagulation/metabolism , Disseminated Intravascular Coagulation/prevention & control , Double-Blind Method , Endotoxemia/metabolism , Endotoxins/antagonists & inhibitors , Female , Fibrinogen/analysis , Fibrinolysis , Gastrointestinal Neoplasms/blood , Gastrointestinal Neoplasms/surgery , Humans , Immunoglobulin G/blood , Interleukin-6/blood , Kupffer Cells/metabolism , Liver Diseases/blood , Liver Diseases/surgery , Liver Failure/blood , Liver Failure/etiology , Male , Membrane Proteins/pharmacology , Middle Aged , Peptide Hydrolases/analysis , Plasminogen/analysis , Postoperative Period , Prospective Studies , Sepsis/etiology , Tissue Plasminogen Activator/analysis , alpha-2-Antiplasmin/analysis , alpha-Macroglobulins/analysis
14.
Liver ; 21(1): 56-63, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11169074

ABSTRACT

BACKGROUND/AIMS: Major liver resection results in a high morbidity and mortality, and endotoxin plays a role in post-resection hepatic failure. Severe hepatic failure as seen in hepatitis and cirrhosis may be accompanied by hepatic encephalopathy and is characterized by a typical plasma amino acid pattern reflected by a decreased Fischer ratio. This study was performed to evaluate the plasma amino acid pattern in patients undergoing major liver surgery receiving placebo or the endotoxin-neutralizing agent bactericidal/permeability-increasing protein (rBPI21). PATIENTS AND METHODS: Forty-eight patients were randomized in this phase II, dose escalation, multicenter trial. Plasma amino acid profiles were determined preoperatively, and on the first (day 1) and third (day 3) postoperative day. RESULTS: In the placebo group the Fischer ratio decreased significantly on both postoperative days. Administration of rBPI21 also resulted in a decreased Fischer ratio on day 1, but not on day 3. Highly elevated alanine plasma levels were observed on day 1 in placebo-treated patients, whereas rBPI21 prevented this elevation. Plasma alanine levels on day 1 correlated with the duration of post-resection hepatic failure. CONCLUSIONS: Major liver resection results in a decreased Fischer ratio and a rise in plasma alanine levels. Plasma levels of alanine on the first postoperative day correlated with the duration of the post-resection hepatic failure. rBPI21 improved the Fischer ratio and prevented the rise of plasma alanine levels.


Subject(s)
Amino Acids, Branched-Chain/blood , Amino Acids, Cyclic/blood , Endotoxins/administration & dosage , Hepatectomy/adverse effects , Hepatic Encephalopathy/drug therapy , Membrane Proteins/administration & dosage , Adult , Aged , Dose-Response Relationship, Drug , Double-Blind Method , Female , Hepatectomy/mortality , Hepatic Encephalopathy/blood , Hepatic Encephalopathy/etiology , Humans , Male , Middle Aged , Treatment Outcome
15.
Eur J Clin Nutr ; 54(8): 615-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10951509

ABSTRACT

OBJECTIVE: Thoracoabdominal aortic surgery is a high-risk procedure and associated with a significant morbidity and mortality. Ischemia reperfusion of visceral organs and lower extremities is one of the most important determinants of this morbidity. Arginine is the precursor of nitric oxide and arginine plasma levels are important in maintaining organ blood flow. Furthermore, arginine is important in wound healing and the immune system. Because of increased utilization of arginine, low arginine plasma levels could be expected after thoracoabdominal aortic surgery. We therefore measured arginine plasma levels in these patients. DESIGN: Six patients with thoracoabdominal aortic aneurysm were included in this study. SETTING: University Hospital Vrije Universiteit, Department of Surgery, Amsterdam, The Netherlands. SUBJECTS: Six patients undergoing thoracoabdominal aortic surgery. INTERVENTION: Plasma levels of arginine were measured by high-performance liquid chromatography. RESULTS: Very low arginine plasma levels were seen on the first postoperative day. From day 1 arginine slowly increased, but did not reach normal plasma levels on day 6. CONCLUSIONS: A significant decrease of arginine plasma levels was found and because of the fact that arginine has multiple functions, it may be important to keep these arginine plasma levels at normal or even higher levels in patients undergoing major vascular surgery. European Journal of Clinical Nutrition (2000) 54, 615-617.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Aortic Aneurysm, Thoracic/surgery , Arginine/blood , Aged , Arginine/physiology , Chromatography, High Pressure Liquid , Female , Humans , Male , Middle Aged
16.
J Hepatol ; 32(3): 399-405, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10735608

ABSTRACT

BACKGROUND/AIMS: The remnant liver after partial hepatectomy releases arginase into the plasma, which is a reliable indicator of hepatocellular damage. Little information is available on how this release affects arginine plasma levels. We hypothesized that Kupffer cells after partial hepatectomy may prevent further hepatocellular damage, contributing to lower arginase release. The aim of the study was to evaluate the role of Kupffer cells in plasma arginase activity and arginine plasma levels after partial hepatectomy. METHODS: Wag/Rij rats (n=72, 250-275 g) were randomly assigned to receive 1 ml liposome-encapsulated dichloromethylene-diphosphonate in order to eliminate Kupffer cells (DMDP, n=24), 1 ml liposome encapsulated-phosphate buffered saline (PBS, n=24) or 1 ml NaCl 0.9% (NaCl, n=24) intravenously. Forty-eight hours later, all rats had a two-third liver resection. Rats were killed at 0, 24, 48 and 96 h after partial hepatectomy. RESULTS: Arginase plasma activity was higher in the DMDP-treated group compared to NaCl and PBS (both p<0.01, p<0.05, p<0.01 and p<0.05 for 0, 24, 48 and 96 h after partial hepatectomy respectively). Arginine plasma levels increased, but were lower in the DMDP group compared to NaCl and PBS (both p<0.05, 24 h after hepatectomy). CONCLUSION: The study showed that Kupffer cell depletion results in a higher arginase release from the remnant liver after partial hepatectomy, indicating a hepatocellular protective function of Kupffer cells. Despite this arginase release, arginine plasma levels were increased after partial hepatectomy.


Subject(s)
Arginase/blood , Arginine/blood , Hepatectomy/methods , Kupffer Cells/pathology , Liver/enzymology , Liver/pathology , Amino Acids/blood , Animals , Kupffer Cells/physiology , Random Allocation , Rats , Rats, Inbred Strains
17.
JPEN J Parenter Enteral Nutr ; 23(5 Suppl): S52-8, 1999.
Article in English | MEDLINE | ID: mdl-10483896

ABSTRACT

BACKGROUND: Recently we have shown that glutamine-enriched enteral nutrition in trauma patients reduced the occurrence of pneumonia, bacteremia, and sepsis. In that study, no clear explanation for these results was found except for lower tumor necrosis factor (TNF)-soluble receptors, suggesting immunomodulation. Here we present data on the course of endocrine and metabolic plasma mediators that were analyzed to provide more insight into the working mechanism of glutamine. METHODS: Endocrine and metabolic mediators were measured in plasma samples taken on admission (day 0) and on days 1, 2, 3, 7, and 10. Glucose, prealbumin, albumin, alanine, C-reactive protein, alpha1-antitrypsin, complement factors, cortisol, glucagon, insulin, and growth hormone were assessed by standard techniques. RESULTS: The rate of feeding, demography, and injury severity did not differ between the glutamine and control group. There was a sustained hyperglycemic response in both groups. Insulin levels rose in the second phase of the period of observation. A moderate cortisol and glucagon response was seen in both groups. There was no alteration in growth hormone levels in either group. C-reactive protein, alpha1-antitrypsin, and complement factors showed similar increases in both groups but levels remained in the normal range. The course of alanine, albumin, and prealbumin also showed no difference between the groups. CONCLUSIONS: Glutamine-enriched enteral nutrition had no influence on the endocrine and metabolic response in trauma patients. Therefore, the reduction in infectious morbidity seen in glutamine-supplemented trauma patients is most likely not explained by a modulation of the humoral stress response and its metabolic consequences.


Subject(s)
Bacteremia/prevention & control , Blood Glucose/drug effects , Enteral Nutrition , Glutamine/therapeutic use , Pneumonia/prevention & control , Sepsis/prevention & control , Wounds and Injuries/classification , Wounds and Injuries/metabolism , Adult , Aged , Alanine/blood , Chromatography, High Pressure Liquid , Double-Blind Method , Female , Glutamine/administration & dosage , Humans , Injury Severity Score , Insulin/blood , Male , Middle Aged , Radioimmunoassay , Wounds and Injuries/blood
18.
Clin Nutr ; 17(1): 23-9, 1998 Feb.
Article in English | MEDLINE | ID: mdl-10205311

ABSTRACT

Twenty critically-ill surgical patients who needed total parenteral nutrition were randomly enrolled in a double-blind study comparing two intravenous fat emulsions: one containing a mixture of 50% medium-chain triglycerides and 50% long-chain triglycerides and another containing 100% longchain triglycerides. The purpose of this study was to investigate metabolic and biochemical differences between both emulsions with special reference to liver enzymes. After a baseline period of 24 h with only glucose and NaCl infusion, the lipid emulsion was added continuously during 24 h over 5 days. The parenteral nutrition was administered in mixture bags containing amino-acids, glucose and lipids together. Two-thirds of the non-protein calories were administered as glucose 40% and one third as either long-chain triglycerides or a mixture of medium-chain triglycerides and long-chain triglycerides. The total amount of non-protein calories received was the measured energy expenditure during the baseline period plus 10% and was fixed during the study. Plasma substrate concentrations, energy expenditure, and nitrogen balance were determined and arterial blood samples were taken. No toxic effects or complications attributable to one of the two emulsions were observed. There was no significant difference in energy expenditure, nitrogen balance, liver function tests, carnitine, transferrin, pre-albumin, albumin, cholesterol, triglycerides and free fatty acids. The only parameter that showed a different pattern of reaction between the two emulsions was serum bilirubin concentration. In this study no evidence of any advantageous effect of a mixture of medium-chain triglycerides and long-chain triglycerides was seen.


Subject(s)
Critical Illness/therapy , Fat Emulsions, Intravenous/administration & dosage , Parenteral Nutrition, Total , Triglycerides/administration & dosage , Adult , Aged , Bilirubin/blood , Carnitine/blood , Double-Blind Method , Energy Intake , Energy Metabolism , Female , Glucose/administration & dosage , Humans , Hydroxybutyrates/blood , Male , Middle Aged , Prospective Studies , Triglycerides/blood , Triglycerides/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...